United States

Cellectis SA (ALCLS.PA)

ALCLS.PA on Paris Stock Exchange

11:35am EDT
Change (% chg)

€-0.06 (-0.25%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Andre Choulika

53 2000 Chairman of the Board, Chief Executive Officer

Thierry Moulin

2014 Chief Financial Officer

Elsy Boglioli

2018 Chief Operating Officer, Executive Vice President - Strategy and Corporate Development

David Sourdive

2008 Executive Vice President-Corporate Development, Director

Stephane Depil

2017 Senior Vice President - Research and Development and Chief Medical Officer